Free Republic
Browse · Search
General/Chat
Topics · Post Article

To: WildHighlander57

630 posted on 04/25/2021 7:44:28 AM PDT by bitt (People who wonder if the glass is half empty or half full miss the point. The glass is refillable.)
[ Post Reply | Private Reply | To 587 | View Replies ]


To: bitt

Very good questions invthat meme!


635 posted on 04/25/2021 7:58:42 AM PDT by WildHighlander57 ((WildHighlander57 returning after lurking since 2000))
[ Post Reply | Private Reply | To 630 | View Replies ]

To: bitt

I missed this story last week:

https://worthypolitics.com/this-is-sickening-sanctuary-state-of-new-york-a-mother-of-8-year-old-boy-was-murdered-in-brutal-attack-by-illegal-alien-ms-13-gang-members/

https://nypost.com/2021/04/16/4-charged-in-connection-to-woman-found-in-queens-trunk-cops/


679 posted on 04/25/2021 10:04:10 AM PDT by bitt (People who wonder if the glass is half empty or half full miss the point. The glass is refillable.)
[ Post Reply | Private Reply | To 630 | View Replies ]

To: bitt

https://nypost.com/2021/04/25/elon-musk-people-will-probably-die-trying-to-get-to-mars/

Elon Musk says ‘bunch of people will probably die’ during Mars mission


688 posted on 04/25/2021 10:18:55 AM PDT by bitt (People who wonder if the glass is half empty or half full miss the point. The glass is refillable.)
[ Post Reply | Private Reply | To 630 | View Replies ]

To: bitt; WildHighlander57
Follow the money.

This is from Moderna's SEC filing.

https://www.sec.gov/Archives/edgar/data/1682852/000168285220000017/mrna-20200630.htm

Key sentence from the "description of the business" section--

Since inception, we have incurred significant net losses. As of June 30, 2020, we had an accumulated deficit of $1.74 billion. We may continue to incur significant expenses and operating losses for the foreseeable future. In addition, we anticipate that our expenses will increase significantly in connection with our ongoing activities to support our platform research, drug discovery and clinical development, infrastructure and Research Engine and Early Development Engine, digital infrastructure, creation of a portfolio of intellectual property, expansion into global markets, and administrative support.

We do not expect to recognize significant revenue from sales of potential mRNA medicines unless and until we successfully complete clinical development and obtain regulatory approval for one or more of our investigational medicines. If we seek to obtain regulatory approval for any of our investigational medicines, we expect to incur significant commercialization expenses. Our investigational vaccine against the novel coronavirus (mRNA-1273), which is currently in clinical trials, has been developed rapidly to respond to the global COVID-19 pandemic. We are expending significant efforts to further the rapid development of this potential vaccine and expect to continue to do so over the next 12 months. These efforts have required and will continue to require the expenditure of significant funds and the establishment of significant worldwide infrastructure and partnerships.

697 posted on 04/25/2021 10:58:42 AM PDT by grey_whiskers (The opinions are solely those of the author and are subject to change with out notice.)
[ Post Reply | Private Reply | To 630 | View Replies ]

To: bitt


709 posted on 04/25/2021 11:35:00 AM PDT by bitt (People who wonder if the glass is half empty or half full miss the point. The glass is refillable.)
[ Post Reply | Private Reply | To 630 | View Replies ]

Free Republic
Browse · Search
General/Chat
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson